ֱ

Meeting Coverage

ACAAI

American College of Allergy, Asthma & Immunology

Novel Drug for Chronic Inducible Urticaria Delivers in Mid-Stage Trial

Impressive responses with barzolvolimab in cold urticaria, symptomatic dermographism

ACAAI over a photo of Hynes Convention Center in Boston, MA.

Latest ACAAI Meeting Coverage

What Is the Optimal Reliever Therapy for Difficult-to-Control Asthma?

Meta-analysis says anti-inflammatory relievers beat bronchodilators in reducing exacerbations

October 28, 2024
Dupilumab Proves Effective in Chronic Spontaneous Urticaria

Significant reduction in hives and itch in antihistamine-resistant patients

October 27, 2024
Gene-Editing Therapy Reduced Attacks in Hereditary Angioedema

Single infusion also reduced total plasma kallikrein protein levels versus placebo

October 24, 2024
Here's Why People Think They Developed Food Allergies

Survey finds that 13% thought genetics were responsible, 27% blamed eating behaviors

November 16, 2023
Added Leukotriene Receptor Antagonists Show Benefits in Chronic Urticaria

Off-label use along with antihistamines improved activity, itch, and wheal count scores

November 15, 2023
Novel BTK Inhibitor for Chronic Hives Wins in Phase III Trials

Remibrutinib demonstrated superiority over placebo in both the REMIX-1 and -2 trials

November 14, 2023
Asthma-Tracking App Shows Some Promise for Reducing ED Visits

No benefit for the privately insured in trial, but participants on Medicaid had lower risk

November 14, 2023
AI Gets It Mostly Right on Allergy Myths

ChatGPT sometimes gave opposite answers, and clinicians themselves didn't always agree

November 13, 2023
Many Primary Care Docs Unfamiliar With Biologics for Asthma

In a survey, 42% of PCPs said they were "not familiar" with biologic therapies for asthma

November 13, 2023
Benefits of Peanut Allergy Skin Patch for Toddlers Grow After First Year

Open-label extension of EPITOPE trial shows increased tolerance at 24 months

November 13, 2023
Peanut Allergy Toothpaste Shows Promise in Phase I Trial

Patients taking the oral mucosal immunotherapy reported only minor adverse effects

November 13, 2023
New Treatment Options on the Horizon for Chronic Spontaneous Urticaria

Monoclonal antibodies, BTK inhibitor alleviate symptoms when antihistamines fall short

November 16, 2022
Skin Patch Helped Young Kids With Peanut Allergies

More kids had responses, decreased symptom severity, versus those who received placebo

November 15, 2022
Sublingual Film Delivers Epinephrine

Pharmacokinetics in healthy cohort looks promising

November 15, 2022

Videos

ACAAI Video Pearls
November 2024